Abstract:Abstract The nerve injury-induced protein 1 (Ninjurin1, Ninj1), a homophilic adhesion molecule, is involved in nerve regeneration, inflammation and vascular regression. Ninj1 is found to be overexpressed in human cancers including hepatocellular carcinoma and acute lymphoblastic leukemia. However, the role of Ninj1 in tumorigenesis has not been elucidated. Recently, we found that Ninj1 is transcriptionally regulated by p53, which in turn regulates p53 expression through mRNA translation. Thus, the mutual regulation between p53 and Ninj1 represents a novel loop in the p53 pathway. To examine the biological significance of the p53-Ninj1 loop, we generated and monitored 4 cohorts of mice: (i) WT, (ii) Ninj1-het, (iii) p53-null, (iv) Ninj1-het; p53-null. We found that Ninj1-het mice were highly prone to skin lesions. We also found that Ninj1 deficiency shortened the life-span but decreased the incidence of sarcoma in mice without p53. Additionally, we found that Ninj1-het; p53-null mice were prone to hydrocephalus and kidney abnormality. To examine the association of Ninj1 with mutant p53, we generated and characterized Ninj1+/-; p53 R270H/- and p53 R270H/- mice. We found that Ninj1 deficiency shortened the life-span and promoted the frequency and aggressiveness of tumors in p53 R270H/- mice. Together, we conclude that Ninj1 differently regulates the tumor susceptibility in a p53-dependent manner in vivo and that the Ninj1-p53 loop plays a pivotal role in tumor suppression and longevity. Citation Format: Hee Jung Yang, Seong Jun Cho, Jin Zhang, Wensheng Yan, Xinbin Chen. Ninjurin1, a target of p53, modulates p53-dependent tumor suppression in vivo. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 675.

A Potential Mechanism for Tumorigenesis Regulation of Insulin-like Growth Factor II P 3 Promoter by p 53 : Updated Version

Regulation of Insulin-Like Growth Factor II P3 Promotor by P53: a Potential Mechanism for Tumorigenesis.

P53 Regulates Human Insulin-Like Growth Factor II Gene Expression Through Active P4 Promoter in Rhabdomyosarcoma Cells.

Insulin-like Growth Factor Factor Binding Protein-2 is a Novel Mediator of P53 Inhibition of Insulin-Like Growth Factor Signaling.

Ninjurinl, A Target Of P53, Modulates P53-Dependent Tumor Suppression In Vivo

Abstract 675: Ninjurin1, a Target of P53, Modulates P53-Dependent Tumor Suppression in Vivo

Inhibition of nonsense-mediated decay rescues p53/ isoform expression and activates the p53 pathway in and select-mutant cancers

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Tumor Suppressor Gene Insulin-Like Growth Factor Binding Protein-Related Protein 1 (Igfbp-Rp1) Induces Senescence-Like Growth Arrest in Colorectal Cancer Cells

Suppression Of Inhibitor Of Differentiation 2, A Target Of Mutant P53, Is Required For Gain-Of-Function Mutations

Insulin Growth Factor-2 Binding Protein 3 (igf2bp3) to Promote Lung Tumorigenesis Viaregulation of P53 Stability.

A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas

Mitofusin-2 is a Novel Direct Target of P53.

Tumor Suppressor RASSF1A Promoter: P53 Binding and Methylation

Mutant IDH uncouples p53 from target gene regulation to disable tumor suppression

Genetic Mechanisms of Tumor Suppression by the Human p53 Gene

E2F1 Regulates P53r2 Gene Expression in P53-Deficient Cells

Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion

Integrated stress response (ISR) activation and apoptosis through HRI kinase by PG3 and other p53 pathway-restoring cancer therapeutics

Post-transcriptional Regulation of P21WAF1/CIP1 by P53